Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00932_DB01195_nanopub.RAkw9bRd8UapoazxlEGLn9NSHcgiyWVtaZiOd8jGhLYYE#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00932_DB01195 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00932_DB01195 label "DDI between Tipranavir and Flecainide - Tipranavir, co-administered with Ritonavir, may increase the plasma concentration of Flecainide. Concomitant therapy is contraindicated. [drugbank_resource:DB00932_DB01195]" assertion.
- drugbank_resource:DB00932_DB01195 identifier "drugbank_resource:DB00932_DB01195" assertion.
- drugbank_resource:DB00932_DB01195 title "DDI between Tipranavir and Flecainide - Tipranavir, co-administered with Ritonavir, may increase the plasma concentration of Flecainide. Concomitant therapy is contraindicated." assertion.
- drugbank:DB00932 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00932_DB01195 assertion.
- drugbank:DB01195 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00932_DB01195 assertion.